Added to YB: 2024-04-22
Pitch date: 2024-04-22
ACRV:US [bullish]
Acrivon Therapeutics, Inc.
-73.54%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Acrivon Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers and develops oncology medicines for patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its generative phosphoproteomics platform.
Market Cap
$70.5M
Pitch Price
$9.56
Price Target
N/A
Dividend
N/A
EV/EBITDA
0.65
P/E
-1.05
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
Acrivon Therapeutics, Inc. ACRV:US
A summary for this pitch has not been created yet.
Read full article (0 min)